Will You Take The Vaccine?

Are you going to take the corona virus vaccine?

  • No.

  • Yes.


Results are only viewable after voting.

DIY-HP-LED

Well-Known Member
US coronavirus: Nearly every new Covid-19 death is now entirely preventable, CDC director says (msn.com)

US coronavirus: Nearly every new Covid-19 death is now entirely preventable, CDC director says

The dangerous Delta variant poses a risk as the United States works to ease out of the Covid-19 pandemic, but experts say the nation has the tools needed to overcome the threat -- if the public takes advantage of them.

"Covid-19 vaccines are available for everyone ages 12 and up," US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said Tuesday at a White House briefing. "They are nearly 100% effective against severe disease and death -- meaning nearly every death due to Covid-19 is particularly tragic, because nearly every death, especially among adults, due to Covid-19 is at this point entirely preventable."

Those still dying from Covid-19 in the US are "overwhelmingly" unvaccinated, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci told CNN.

As of Wednesday, 65.6% of the adult population in the US have received at least one dose of a Covid-19 vaccine, according to the CDC. While that seems close to President Joe Biden's goal of having 70% of American adults at least partially vaccinated by July 4, experts are concerned about declining rates of new vaccinations and the difficulty in motivating those still hesitant to get inoculated.

"This virus is an opportunist," Walensky said. "As long as there are those who are not vaccinated, Covid-19 will remain a threat."

The Delta variant, which is believed to be more transmissible and more dangerous, could be the dominant strain in areas of the US that have low vaccination rates in a matter of weeks, Fauci told "CBS This Morning" on Wednesday.

While Fauci thinks a return to the high virus numbers of 2020 is unlikely, communities with low vaccination rates could experience localized surges because of the Delta variant, he said earlier this week. Full vaccination with current vaccines is effective against the variant, he has said.

"For those areas where you have a high vaccination rate, you're not going to see" Delta become dominant, Fauci told CBS. "Again, another powerful reason why we need to get vaccinated."

Even if 75% of eligible Americans were vaccinated, a Delta-like variant could result in Covid-19 bouncing back from summer lows to cause more than 3,000 deaths per week in the US at various points during the fall and winter, a recent research model showed.

That would be about 1,000 more Covid-19 deaths than the US has seen over the past week, though still far below the peak of 24,000 deaths during the second week of January, according to the model from the Covid-19 Scenario Modeling Hub, a project involving researchers from 13 institutions.
 

printer

Well-Known Member
"To put this into perspective, if we vaccinate 1 million 12-17 year olds, we could see 30-40 MILD cases of myocarditis. In this same 1 million, through vaccination we AVOID: 8,000 cases of COVID-19, 200 hospitalizations, 50 ICU stays & 1 death. The benefits far outweigh the risks."
Except for the 30-40 12-17 year olds. Sounds like communism to me.
 

DIY-HP-LED

Well-Known Member
"In this context, the success of the Novavax vaccine should be A1 news. The recent results confirm that it has roughly the same efficacy as the two authorized mRNA vaccines, with the added benefit of being based on an older, more familiar science. The protein-subunit approach used by Novavax was first implemented for the hepatitis B vaccine, which has been used in the U.S. since 1986. The pertussis vaccine, which is required for almost all children in U.S. public schools, is also made this way. Some of those people who have been wary of getting the mRNA vaccines may find Novavax more appealing.

The Novavax vaccine also has a substantially lower rate of side effects than the authorized mRNA vaccines. Last week’s data showed that about 40 percent of people who receive Novavax report fatigue after the second dose, as compared with 65 percent for Moderna and more than 55 percent for Pfizer. Based on the results of Novavax’s first efficacy trial in the U.K., side effects (including but not limited to fatigue) aren’t just less frequent; they’re milder too. That’s a very big deal for people on hourly wages, who already bear a disproportionate risk of getting COVID-19, and who have been less likely to get vaccinated in part because of the risk of losing days of work to post-vaccine fever, pain, or malaise. Side effects are a big barrier for COVID-vaccine acceptance. The CDC reported on Monday that, according to a survey conducted in the spring, only about half of adults under the age of 40 have gotten the vaccine or definitely intend to do so, and that, among the rest, 56 percent say they are concerned about side effects. Lower rates of adverse events are likely to be a bigger issue still for parents, when considering vaccination for their children."
---------------------------------------------------------------------------------------------------------------------------------
Novavax Is Now the Best COVID-19 Vaccine - The Atlantic

The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
Persistent hype around mRNA vaccine technology is now distracting us from other ways to end the pandemic.

At the end of January, reports that yet another COVID-19 vaccine had succeeded in its clinical trials—this one offering about 70 percent protection—were front-page news in the United States, and occasioned push alerts on millions of phones. But when the Maryland-based biotech firm Novavax announced its latest stunning trial results last week, and an efficacy rate of more than 90 percent even against coronavirus variants, the response from the same media outlets was muted in comparison. The difference, of course, was the timing: With three vaccines already authorized for emergency use by the U.S. Food and Drug Administration, the nation is “awash in other shots” already, as the The New York Times put it.
...
 

CatHedral

Well-Known Member
"In this context, the success of the Novavax vaccine should be A1 news. The recent results confirm that it has roughly the same efficacy as the two authorized mRNA vaccines, with the added benefit of being based on an older, more familiar science. The protein-subunit approach used by Novavax was first implemented for the hepatitis B vaccine, which has been used in the U.S. since 1986. The pertussis vaccine, which is required for almost all children in U.S. public schools, is also made this way. Some of those people who have been wary of getting the mRNA vaccines may find Novavax more appealing.

The Novavax vaccine also has a substantially lower rate of side effects than the authorized mRNA vaccines. Last week’s data showed that about 40 percent of people who receive Novavax report fatigue after the second dose, as compared with 65 percent for Moderna and more than 55 percent for Pfizer. Based on the results of Novavax’s first efficacy trial in the U.K., side effects (including but not limited to fatigue) aren’t just less frequent; they’re milder too. That’s a very big deal for people on hourly wages, who already bear a disproportionate risk of getting COVID-19, and who have been less likely to get vaccinated in part because of the risk of losing days of work to post-vaccine fever, pain, or malaise. Side effects are a big barrier for COVID-vaccine acceptance. The CDC reported on Monday that, according to a survey conducted in the spring, only about half of adults under the age of 40 have gotten the vaccine or definitely intend to do so, and that, among the rest, 56 percent say they are concerned about side effects. Lower rates of adverse events are likely to be a bigger issue still for parents, when considering vaccination for their children."
---------------------------------------------------------------------------------------------------------------------------------
Novavax Is Now the Best COVID-19 Vaccine - The Atlantic

The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
Persistent hype around mRNA vaccine technology is now distracting us from other ways to end the pandemic.

At the end of January, reports that yet another COVID-19 vaccine had succeeded in its clinical trials—this one offering about 70 percent protection—were front-page news in the United States, and occasioned push alerts on millions of phones. But when the Maryland-based biotech firm Novavax announced its latest stunning trial results last week, and an efficacy rate of more than 90 percent even against coronavirus variants, the response from the same media outlets was muted in comparison. The difference, of course, was the timing: With three vaccines already authorized for emergency use by the U.S. Food and Drug Administration, the nation is “awash in other shots” already, as the The New York Times put it.
...
I question some of the language in this press release as containing a Luddite value judgment.

Imagine if Road and Track ran an article about a new GT that was competitive with McLarens and Corvettes on a road course, but had the added benefit of a wooden frame.

The new vax tech is more scalable and quicker to manufacture than the old. Even so, I think Novavax is a valuable horse in the stable. But it is a Morgan among McLarens.
 

Sofa King Smoooth

Well-Known Member
I question some of the language in this press release as containing a Luddite value judgment.

Imagine if Road and Track ran an article about a new GT that was competitive with McLarens and Corvettes on a road course, but had the added benefit of a wooden frame.

The new vax tech is more scalable and quicker to manufacture than the old. Even so, I think Novavax is a valuable horse in the stable. But it is a Morgan among McLarens.
If it gets people to take the vaccine it's as technically advanced as it needs to be.

It doesnt have those scary letters in it, RNA
 

DIY-HP-LED

Well-Known Member
I question some of the language in this press release as containing a Luddite value judgment.

Imagine if Road and Track ran an article about a new GT that was competitive with McLarens and Corvettes on a road course, but had the added benefit of a wooden frame.

The new vax tech is more scalable and quicker to manufacture than the old. Even so, I think Novavax is a valuable horse in the stable. But it is a Morgan among McLarens.
It is cheap and easy to produce, is highly effective, works against variants and the world needs 10 billion doses ASAP. We could also use other options with fewer side effects, for kids for instance. Also it can be made in existing facilities like many traditional vaccines, mRNA vaccines need new facilities, specialized equipment and feed stocks. mRNA is the way of the future and provides fast response, though many mRNA approaches have failed in trials too. There will be many vaccine programs halted now that we have more successful candidates, there were a couple of hundred contenders in total.

Also moving forward volunteers for vaccine trials will be difficult to find among those who are vaccine reluctant or resistant! If taking a proven vaccine bothers them, imagine their reaction to trying an experimental one as part of a clinical trial! Some might be candidates for treatments though, so they will be useful for something! :lol:
 

CatHedral

Well-Known Member
It is cheap and easy to produce, is highly effective, works against variants and the world needs 10 billion doses ASAP. We could also use other options with fewer side effects, for kids for instance. Also it can be made in existing facilities like many traditional vaccines, mRNA vaccines need new facilities, specialized equipment and feed stocks. mRNA is the way of the future and provides fast response, though many mRNA approaches have failed in trials too. There will be many vaccine programs halted now that we have more successful candidates, there were a couple of hundred contenders in total.

Also moving forward volunteers for vaccine trials will be difficult to find among those who are vaccine reluctant or resistant! If taking a proven vaccine bothers them, imagine their reaction to trying an experimental one as part of a clinical trial! Some might be candidates for treatments though, so they will be useful for something! :lol:
I completely agree that more vaccine = better. But that vaccine is no more "proven" than the new-tech ones. It's that implication of older = better that caught my eye.

I have absolutely no handle on the cost, scalability and speed of delivery vs, say, Pfizer. But this looks like an excellent candidiate for vaccine diplomacy. Imagine giving Russians stuff that works "made in USA". Neener, Vladimir.
 

CatHedral

Well-Known Member
It was the Atlantic, not Nature or PNAS! More an opinion piece really and meant for general consumption.
I like to think that the Atlantic is old-school journalism with the standards that go with it, and not picked cherries like Reader's Digest.

Especially general-consumption pieces need to be clear about the difference between objective items and derived opinions. Call it critical thoiught theory.
 

printer

Well-Known Member
It is cheap and easy to produce, is highly effective, works against variants and the world needs 10 billion doses ASAP. We could also use other options with fewer side effects, for kids for instance. Also it can be made in existing facilities like many traditional vaccines, mRNA vaccines need new facilities, specialized equipment and feed stocks. mRNA is the way of the future and provides fast response, though many mRNA approaches have failed in trials too. There will be many vaccine programs halted now that we have more successful candidates, there were a couple of hundred contenders in total.

Also moving forward volunteers for vaccine trials will be difficult to find among those who are vaccine reluctant or resistant! If taking a proven vaccine bothers them, imagine their reaction to trying an experimental one as part of a clinical trial! Some might be candidates for treatments though, so they will be useful for something! :lol:
If it was all that and a bag of potato chips it would be produced and sold to the rest of the world. I had to put together a capabilities blurb to hawk a rocket. I looked over all the tests and data and, well there were holes. I brought it up and I was told, "Don't lie but just push the positive points." Not that it was a bad rocket, it was used for many years.
 

DIY-HP-LED

Well-Known Member
Missouri becomes hot spot for Delta variant fueling hospitalizations while vaccination efforts lag - CNN

Missouri becomes hot spot for Delta variant fueling hospitalizations while vaccination efforts lag

(CNN)In June, Louie Michael and his wife, Patti, were admitted as Covid-19 patients at Springfield's Mercy Hospital, one of two major hospitals in southwest Missouri.

Pattie was hospitalized first. She has asthma and is immunocompromised. Michael followed the next day, arriving by ambulance.

He chronicled his bout with Covid-19 on Facebook, sharing his health updates daily. "The breathing is labored, it's tough. This stuff is real," said Michael.

Speaking to the Springfield News-Leader, Michael said the couple never entirely ruled out the vaccine, but they did put off the decision, waiting to see the results between the available vaccines.
Something they now regret.

"I hope people do think about getting the vaccination. It's your prerogative, but I wish I had done it just to just avoid this," Michael said. "This new Delta variant, which they do think that I might have had, is just dive bombing everybody who didn't get the other before."

Missouri is seeing a concerning uptick in hospitalizations due to Covid-19's Delta variant, which originated in India. In Springfield alone, there has been a 225% increase in hospital admissions since June 1, according to the Springfield-Greene County Health Department

The Delta variant -- which has been found to be more transmissible than others -- now accounts for about 29% of cases in Missouri, more than any other state, according to data from the US Centers for Disease Control and Prevention.

And vaccination rates in Missouri remain below average, CDC data shows. About 38% of the state's population is fully vaccinated, compared to nearly 46% of the US population overall.
...
 

DIY-HP-LED

Well-Known Member
Colorado has fast rising numbers of the Delta variant with a low vaccination rate and the hospitals are filling up so what do they do?
They have a huge 3 day country music festival that started yesterday, what could go wrong?
Mountain morons, not many at a country music festival will vaccinated and there won't be a mask in sight. Lot's of drunks, MAGA hats and fights though.
 

DIY-HP-LED

Well-Known Member
Colorado has fast rising numbers of the Delta variant with a low vaccination rate and the hospitals are filling up so what do they do?
They have a huge 3 day country music festival that started yesterday, what could go wrong?
Donald should be starting up his MAGA/ Stop the steal rally super spreader events soon, not many will be vaccinated at them or wear a mask. Donald will leave another trail of misery maiming and death in the wake of his farewell tour, as he tries to grift more money out of his base for legal fees. We will soon see what king shit has to say about DeSantis, Pence and all those rats who will be testifying against him, he will whine about it constantly.

Look for Donald's Delta Death tour in your state this summer. D3 for short.
 
Top